Gynaecomastia Associated with Proton Pump Inhibitors: A Case Series from the Spanish Pharmacovigilance System

Author： Carvajal Alfonso   Macias Diego   Gutiérrez Angélica   Ortega Sara   Sáinz María   Arias Luis H. Martín   Velasco Alfonso  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.30, Iss.6, 2007-01, pp. : 527-531

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Proton pump inhibitors: Hypomagnesaemia: 4 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1313, 2010-01 ,pp. : 36-37

Adis International

Access to resources Recommend Favorite

Continuation of Proton Pump Inhibitors from Hospital to Community

By Grant Kenneth   Al-Adhami Noor   Tordoff June   Livesey Jocelyn   Barbezat Gil   Reith David  

Pharmacy World and Science, Vol. 28, Iss. 4, 2006-08 ,pp. : 189-193

Springer Publishing Company

Access to resources Recommend Favorite

The EMA's Pharmacovigilance Working Party (PhVWP) is recommending that labels for proton pump inhibitors (PPIs) be updated

By  

Reactions Weekly, Vol. 1, Iss. 1397, 2012-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Hypomagnesemia and proton-pump inhibitors

By Famularo Giuseppe   Gasbarrone Laura   Minisola Giovanni  

Expert Opinion on Drug Safety, Vol. 12, Iss. 5, 2013-09 ,pp. : 709-716

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenomics of proton pump inhibitors

By Furuta Takahisa   Shirai Naohito   Sugimoto Mitsushige   Ohashi Kyoichi   Ishizaki Takashi  

Pharmacogenomics, Vol. 5, Iss. 2, 2004-03 ,pp. : 181-202

Future Medicine

Access to resources Recommend Favorite